Sample_ID,Sample_Name,NAME,Rep,MOA,Abbr,Compound,Dose,Duration,vehicle,route,vehicle_route_designation,RIN,Platform,Sample_ID,MA_hybDate,MA_dataset,RS_run,RS_platform,RS_Mbases,RS_readDepth,RS_length,RS_date,RS_ercc ratio,RS_ercc spike in,TS_run,TS_Mbases
98141,Rat_Liver_Vehicle__5d_NN_OG_Rep1,Control_0_5d_NN_OG_Rep1,Rep1,Control,NN_OG,Vehicle,0,5d,SALINE 100 %,ORAL GAVAGE,NN_OG,9.5,MRT,98141,02/15/06,Training Set,SRR1178062,HiSeq2000,12239,63532352,2x101 nt,12.16.11,0.73,Mix1,SRR7746584,153
98482,Rat_Liver_Vehicle__5d_NN_OG_Rep6,Control_0_5d_NN_OG_Rep6,Rep6,Control,NN_OG,Vehicle,0,5d,CMC .5 %,ORAL GAVAGE,NN_OG,9.4,MRT,98482,02/28/06,Training Set,SRR1178066,HiSeq2000,10825,56193848,2x101 nt,12.16.11,0.79,Mix1,SRR7746588,143
98543,Rat_Liver_Vehicle__5d_NN_OG_Rep3,Control_0_5d_NN_OG_Rep3,Rep3,Control,NN_OG,Vehicle,0,5d,CMC .5 %,ORAL GAVAGE,NN_OG,9.4,MRT,98543,02/21/06,Training Set,SRR1178067,HiSeq2000,7923,41130904,2x101 nt,12.16.11,0.63,Mix2,SRR7746589,140
98379,Rat_Liver_PIRINIXIC-ACID_364mg/kg_5d_NN_OG_Rep1,PIR_364mg/kg_5d_NN_OG_Rep1,Rep1,PPARA,PIR,PIRINIXIC ACID,364mg/kg,5d,CMC .5 %,ORAL GAVAGE,NN_OG,9.7,MRT,98379,02/15/06,Training Set,SRR1177963,HiScanSQ,3447,17896530,2x101 nt,09.30.11,0.79,Mix2,SRR7746625,144
98455,Rat_Liver_PIRINIXIC-ACID_364mg/kg_5d_NN_OG_Rep2,PIR_364mg/kg_5d_NN_OG_Rep2,Rep2,PPARA,PIR,PIRINIXIC ACID,364mg/kg,5d,CMC .5 %,ORAL GAVAGE,NN_OG,9.7,MRT,98455,02/16/06,Training Set,SRR1177964,HiScanSQ,3726,19342390,2x101 nt,09.30.11,0.81,Mix2,SRR7746626,142
98518,Rat_Liver_PIRINIXIC-ACID_364mg/kg_5d_NN_OG_Rep3,PIR_364mg/kg_5d_NN_OG_Rep3,Rep3,PPARA,PIR,PIRINIXIC ACID,364mg/kg,5d,CMC .5 %,ORAL GAVAGE,NN_OG,9.6,MRT,98518,02/21/06,Training Set,SRR1177965,HiScanSQ,3245,16848750,2x101 nt,09.30.11,0.72,Mix2,SRR7746627,146
